abnormal xenobiotic pharmacokinetics_Abcb1b<tm2Bor>/Abcb1b<tm2Bor>

http://metadb.riken.jp/0008875I129P2OlaHsdFVBAbcb1btm2BorAbcb1btm2BorAbcb1btm2Bor

abnormal xenobiotic pharmacokinetics_Abcb1b<tm2Bor>/Abcb1b<tm2Bor>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• ATP-binding cassette, sub-family B (MDR/TAP), member 1B
  http://metadb.riken.jp/db/mgi_rdf/MGI:97568

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Abcb1b<tm2Bor>/Abcb1b<tm2Bor>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Abcb1b<tm2Bor>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * FVB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal xenobiotic pharmacokinetics
  http://purl.obolibrary.org/obo/MP_0008875

文献

http://purl.org/net/cito/citesAsAuthority

• A H. Schinkel, et.al., Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins., Proceedings of the National Academy of Sciences of the United States of America, 1997, 94
  http://rdf.ncbi.nlm.nih.gov/pubmed/9108099